Periostin increases migration and proliferation of human periodontal ligament fibroblasts challenged by tumor necrosis factor -α and Porphyromonas gingivalis lipopolysaccharides

Journal of Periodontal Research

Volumn 49, Issue 3, 2014, Pages 405-414

  Padial Molina, M ^a,b   Volk, S L ^a   Rios, H F ^a,c  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cell migration; Cell proliferation; Periodontal disease; Periodontal ligament; Periostin

Indexed keywords

CELL ADHESION MOLECULE; FIBROBLAST GROWTH FACTOR 2; KI 67 ANTIGEN; LIPOPOLYSACCHARIDE; MTOR PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; POSTN PROTEIN, HUMAN; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; HUMAN; PERIODONTAL LIGAMENT; PHOSPHORYLATION; PHYSIOLOGY; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION;

CELL ADHESION MOLECULES; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HUMANS; KI-67 ANTIGEN; LIPOPOLYSACCHARIDES; PERIODONTAL LIGAMENT; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PORPHYROMONAS GINGIVALIS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899633181     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12120     Document Type: Article

References (47)

1. Bartold PM, Narayanan AS. Molecular and cell biology of healthy and diseased periodontal tissues. Periodontol 2000 2006;40:29-49.
2. Rios HF, Ma D, Xie Y et al. Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J Periodontol 2008;79:1480-1490.
3. Papapanou PN. The prevalence of periodontitis in the US: forget what you were told. J Dent Res 2012;91:907-908.
4. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 2012;91:914-920.
5. Bartold PM, Shi S, Gronthos S. Stem cells and periodontal regeneration. Periodontol 2000 2006;40:164-172.
6. Chen FM, An Y, Zhang R, Zhang M. New insights into and novel applications of release technology for periodontal reconstructive therapies. J Control Release 2011;149:92-110.
7. Padial-Molina M, Marchesan JT, Taut AD, Jin Q, Giannobile WV, Rios HF. Methods to validate tooth-supporting regenerative therapies. Methods Mol Biol 2012;887:135-148.
8. Saito Y, Yoshizawa T, Takizawa F et al. A cell line with characteristics of the periodontal ligament fibroblasts is negatively regulated for mineralization and Runx2/Cbfa1/Osf2 activity, part of which can be overcome by bone morphogenetic protein-2. J Cell Sci 2002;115:4191-4200.
9. Ma D, Zhang R, Sun Y et al. A novel role of periostin in postnatal tooth formation and mineralization. J Biol Chem 2011;286:4302-4309.
10. Rios H, Koushik SV, Wang H et al. Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol 2005;25:11131-11144.
11. Hamilton DW. Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal 2008;2:9-17.
12. Norris RA, Damon B, Mironov V et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007;101:695-711.
13. Padial-Molina M, Volk SL, Rodriguez JC, Marchesan JT, Galindo-Moreno P, Rios HF. TNF-alpha and P. gingivalis lipopolysaccharides decrease periostin in human PDL fibroblasts. J Periodontol 2012;84:694-703.
14. Padial-Molina M, Volk SL, Taut AD, Giannobile WV, Rios HF. Periostin is down-regulated during periodontal inflammation. J Dent Res 2012;91:1078-1084.
15. Kuhn B, del Monte F, Hajjar RJ et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 2007;13:962-969.
16. Nishiyama T, Kii I, Kashima TG et al. Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing. PLoS ONE 2011;6:e18410.
17. Bao S, Ouyang G, Bai X et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 2004;5:329-339.
18. Li G, Jin R, Norris RA et al. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 2010;208:358-365.
19. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007;2:329-333.
20. Park CH, Rios HF, Jin Q et al. Tissue engineering bone-ligament complexes using fiber-guiding scaffolds. Biomaterials 2012;33:137-145.
21. Suzuki H, Amizuka N, Kii I et al. Immunohistochemical localization of periostin in tooth and its surrounding tissues in mouse mandibles during development. Anat Rec A Discov Mol Cell Evol Biol 2004;281:1264-1275.
22. Dorn GW II. Periostin and myocardial repair, regeneration, and recovery. N Engl J Med 2007;357:1552-1554.
23. Polizzotti BD, Arab S, Kuhn B. Intrapericardial delivery of gelfoam enables the targeted delivery of periostin peptide after myocardial infarction by inducing fibrin clot formation. PLoS ONE 2012;7:e36788.
24. Zhu M, Fejzo MS, Anderson L et al. Periostin promotes ovarian cancer angiogenesis and metastasis. Gynecol Oncol 2010;119:337-344.
25. Wang Z, Ouyang G. Periostin: a bridge between cancer stem cells and their metastatic niche. Cell Stem Cell 2012;10:111-112.
26. Malanchi I, Santamaria-Martinez A, Susanto E et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012;481:85-89.
27. Utispan K, Sonongbua J, Thuwajit P et al. Periostin activates integrin alpha5beta1 through a PI3K/AKTdependent pathway in invasion of cholangiocarcinoma. Int J Oncol 2012;41:1110-1118.
28. Saitoh M, Pullen N, Brennan P, Cantrell D, Dennis PB, Thomas G. Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J Biol Chem 2002;277:20104-20112.
29. Hosokawa Y, Hosokawa I, Ozaki K et al. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease. Clin Exp Immunol 2005;141:467-474.
30. Quintero JC, Piesco NP, Langkamp HH, Bowen L, Agarwal S. LPS responsiveness in periodontal ligament cells is regulated by tumor necrosis factor-alpha. J Dent Res 1995;74:1802-1811.
31. Thammasitboon K, Goldring SR, Boch JA. Role of macrophages in LPS-induced osteoblast and PDL cell apoptosis. Bone 2006;38:845-852.
32. Wang PL, Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and toll-like receptors. Crit Rev Oral Biol Med 2002;13:132-142.
33. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003;66:1403-1408.
34. Alikhani M, Alikhani Z, Graves DT. Apoptotic effects of LPS on fibroblasts are indirectly mediated through TNFR1. J Dent Res 2004;83:671-676.
35. Nevins M, Giannobile WV, McGuire MK et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol 2005;76:2205-2215.
36. Nevins M, Kao RT, McGuire MK et al. Platelet-derived growth factor promotes periodontal regeneration in localized osseous defects: 36-month extension results from a randomized, controlled, double-masked clinical trial. J Periodontol 2013;84:456-464.
37. Ivanovski S, Gronthos S, Shi S, Bartold PM. Stem cells in the periodontal ligament. Oral Dis 2006;12:358-363.
38. Nagatomo K, Komaki M, Sekiya I et al. Stem cell properties of human periodontal ligament cells. J Periodontal Res 2006;41:303-310.
39. Somerman MJ, Young MF, Foster RA, Moehring JM, Imm G, Sauk JJ. Characteristics of human periodontal ligament cells in vitro. Arch Oral Biol 1990;35:241-247.
40. Pitaru S, McCulloch CA, Narayanan SA. Cellular origins and differentiation control mechanisms during periodontal development and wound healing. J Periodontal Res 1994;29:81-94.
41. Kitamura M, Nakashima K, Kowashi Y et al. Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial. PLoS ONE 2008;3:e2611.
42. Kitamura M, Akamatsu M, Machigashira M et al. FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res 2011;90:35-40.
43. Takayama S, Yoshida J, Hirano H, Okada H, Murakami S. Effects of basic fibroblast growth factor on human gingival epithelial cells. J Periodontol 2002;73:1467-1473.
44. Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V, Le Bourhis X. FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev 2000;11:295-302.
45. Shimabukuro Y, Terashima H, Takedachi M et al. Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction. J Cell Physiol 2011;226:809-821.
46. Murakami S. Periodontal tissue regeneration by signaling molecule(s): what role does basic fibroblast growth factor (FGF-2) have in periodontal therapy? Periodontol 2000 2011;56:188-208.
47. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Bohlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987;84:5277-5281.